{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:24Z","timestamp":1762876044045},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12098-019-02861-3","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T10:42:35Z","timestamp":1549881755000},"page":"740-745","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of Latent Tuberculosis Infection in Children from Developing Countries"],"prefix":"10.1007","volume":"86","author":[{"given":"Agam","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"2861_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372:2127\u201335.","journal-title":"N Engl J Med"},{"key":"2861_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-065X.2010.00984.x","volume":"240","author":"DG Russell","year":"2011","unstructured":"Russell DG. Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev. 2011;240:252\u201368.","journal-title":"Immunol Rev"},{"key":"2861_CR3","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai M, Behr MA, Dowdy D, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076.","journal-title":"Nat Rev Dis Primers"},{"key":"2861_CR4","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(14)70245-1","volume":"2","author":"PJ Dodd","year":"2014","unstructured":"Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014;2:e453\u20139.","journal-title":"Lancet Glob Health"},{"key":"2861_CR5","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RMGJ Houben","year":"2016","unstructured":"Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13:e1002152.","journal-title":"PLoS Med"},{"key":"2861_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2471\/BLT.06.037804","volume":"86","author":"F Leth van","year":"2008","unstructured":"van Leth F, van der Werf MJ, Borgdorff MW. Prevalence of tuberculous infection and incidence of tuberculosis, a re-assessment of the Styblo rule. Bull World Health Org. 2008;86:20\u20136.","journal-title":"Bull World Health Org"},{"key":"2861_CR7","unstructured":"WHO | WHO End TB Strategy [Internet]. WHO. Available at: http:\/\/www.who.int\/tb\/post2015_strategy\/en\/ . Accessed 9\u00a0Sept 2018."},{"key":"2861_CR8","doi-asserted-by":"crossref","unstructured":"Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med [Internet]. 2011;8:18. Available at: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3022524\/ . Accessed 9 Sept 2018.","DOI":"10.1371\/journal.pmed.1000391"},{"key":"2861_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1586\/eri.12.150","volume":"11","author":"A Nienhaus","year":"2013","unstructured":"Nienhaus A, Ringshausen FC, Costa JT, Schablon A, Tripodi D. IFN-\u03b3 release assay versus tuberculin skin test for monitoring TB infection in healthcare workers. Expert Rev Anti-Infect Ther. 2013;11:37\u201348.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2861_CR10","first-page":"1192","volume":"10","author":"M Farhat","year":"2006","unstructured":"Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192\u2013204.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2861_CR11","first-page":"23","volume":"3","author":"S Lockman","year":"1999","unstructured":"Lockman S, Tappero JW, Kenyon TA, Rumisha D, Huebner RE, Binkin NJ. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. Int J Tuberc Lung Dis. 1999;3:23\u201330.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2861_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","volume":"189","author":"SE Dorman","year":"2014","unstructured":"Dorman SE, Belknap R, Graviss EA, et al. Interferon-\u03b3 release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014;189:77\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"2861_CR13","unstructured":"WHO | Latent TB Infection\u00a0: Updated and consolidated Guidelines for Programmatic Management [Internet]. WHO. Available at: http:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection\/en\/ . Accessed\u00a09\u00a0Sept 2018."},{"key":"2861_CR14","first-page":"CD000171","volume":"1","author":"C Akolo","year":"2010","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.","journal-title":"Cochrane Database Syst Rev"},{"key":"2861_CR15","first-page":"CD006418","volume":"8","author":"M Zunza","year":"2017","unstructured":"Zunza M, Gray DM, Young T, Cotton M, Zar HJ. Isoniazid for preventing tuberculosis in HIV-infected children. Cochrane Database Syst Rev. 2017;8:CD006418.","journal-title":"Cochrane Database Syst Rev"},{"key":"2861_CR16","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","volume":"5","author":"A Badje","year":"2017","unstructured":"Badje A, Moh R, Gabillard D, et al. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. Lancet Glob Health. 2017;5:e1080\u20139.","journal-title":"Lancet Glob Health"},{"key":"2861_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","volume":"99","author":"GW Comstock","year":"1974","unstructured":"Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99:131\u20138.","journal-title":"Am J Epidemiol"},{"key":"2861_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1164\/art.1954.70.6.1009","volume":"70","author":"LD Zeidberg","year":"1954","unstructured":"Zeidberg LD, Dillon A, Gass RS. Risk of developing tuberculosis among children of tuberculous parents. Am Rev Tuberc Pulm Dis. 1954;70:1009\u201319.","journal-title":"Am Rev Tuberc Pulm Dis"},{"key":"2861_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1183\/09031936.00070812","volume":"41","author":"GJ Fox","year":"2013","unstructured":"Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013;41:140\u201356.","journal-title":"Eur Respir J"},{"key":"2861_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1473-3099(08)70071-9","volume":"8","author":"J Morrison","year":"2008","unstructured":"Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8:359\u201368.","journal-title":"Lancet Infect Dis"},{"key":"2861_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa1714284","volume":"379","author":"T Diallo","year":"2018","unstructured":"Diallo T, Adjobimey M, Ruslami R, et al. Safety and side effects of rifampin versus isoniazid in children. New Engl J Med. 2018;379:454\u201363.","journal-title":"New Engl J Med"},{"key":"2861_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7326\/M17-0609","volume":"167","author":"D Zenner","year":"2017","unstructured":"Zenner D, Beer N, Harris RJ, Lipman MC, Stagg HR, van der Werf MJ. Treatment of latent tuberculosis infection: an updated network meta-analysis. Ann Intern Med. 2017;167:248\u201355.","journal-title":"Ann Intern Med"},{"key":"2861_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1086\/520983","volume":"45","author":"NP Spyridis","year":"2007","unstructured":"Spyridis NP, Spyridis PG, Gelesme A, et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis. 2007;45:715\u201322.","journal-title":"Clin Infect Dis"},{"key":"2861_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","volume":"169","author":"ME Villarino","year":"2015","unstructured":"Villarino ME, Scott NA, Weis SE, et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015;169:247\u201355.","journal-title":"JAMA Pediatr"},{"key":"2861_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3201\/eid1205.050681","volume":"12","author":"ME Balcells","year":"2006","unstructured":"Balcells ME, Thomas SL, Godfrey-Faussett P, Grant AD. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis. 2006;12:744\u201351.","journal-title":"Emerg Infect Dis"},{"key":"2861_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.5588\/ijtld.15.0908","volume":"20","author":"S Boon den","year":"2016","unstructured":"den Boon S, Matteelli A, Getahun H. Rifampicin resistance after treatment for latent tuberculous infection: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2016;20:1065\u201371.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2861_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1179\/2046905515Y.0000000041","volume":"36","author":"S Prajapati","year":"2016","unstructured":"Prajapati S, Upadhyay K, Mukherjee A, et al. High prevalence of primary drug resistance in children with intrathoracic tuberculosis in India. Paediatr Int Child Health. 2016;36:214\u20138.","journal-title":"Paediatr Int Child Health"},{"key":"2861_CR28","doi-asserted-by":"publisher","first-page":"k2738","DOI":"10.1136\/bmj.k2738","volume":"362","author":"MA Behr","year":"2018","unstructured":"Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ. 2018;362:k2738.","journal-title":"BMJ"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-019-02861-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-02861-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-02861-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T18:28:19Z","timestamp":1662920899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-019-02861-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2861"],"URL":"https:\/\/doi.org\/10.1007\/s12098-019-02861-3","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"28 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of Funding"}}]}}